<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mosaic RASopathies: Genotype analysis of mosaic nevoid proliferations</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mosaic RASopathies: Genotype analysis of mosaic nevoid proliferations</h1>
<div class="graphic"><div class="figure"><div class="ttl">Mosaic RASopathies: Genotype analysis of mosaic nevoid proliferations</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="20%"></colgroup><colgroup span="7" width="7%"></colgroup><colgroup width="11%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2"> </td> <td class="subtitle1" colspan="4"><em>HRAS</em></td> <td class="subtitle1" colspan="2"><em>KRAS</em></td> <td class="subtitle1"><em>NRAS</em></td> <td class="subtitle1"> </td> </tr> <tr> <td class="subtitle2">Nevus type</td> <td class="subtitle2">Mutation analyses*</td> <td class="subtitle2">G13R</td> <td class="subtitle2">G12D</td> <td class="subtitle2">G12C</td> <td class="subtitle2">Other<sup>¶</sup></td> <td class="subtitle2">G12D</td> <td class="subtitle2">G12V</td> <td class="subtitle2">Other<sup>¶</sup></td> <td class="subtitle2">Other<sup>¶</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="10">Keratinocytic</td> </tr> <tr> <td class="indent1">KEN plus urothelial carcinomas<sup>Δ</sup><sup>[1]</sup></td> <td>Sanger sequencing</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">G12S</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="indent1">KEN<sup>[2]</sup></td> <td>SNaPshot assay, Sanger sequencing</td> <td class="centered">21/72</td> <td class="centered"> </td> <td class="centered">1/72</td> <td class="centered">G12V, Q61L</td> <td class="centered">1/72</td> <td class="centered"> </td> <td class="centered">G12D, P34L, Q61R</td> <td><em>FGFR3</em> (16/72), <em>PIK3CA</em> (6/72)</td> </tr> <tr class="divider_bottom"> <td class="indent1">KEN plus rhabdomyosarcoma<sup>Δ</sup><sup>[3]</sup></td> <td>WGA-aCGH</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">1/1</td> <td class="centered"> </td> <td class="centered"> </td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="10">Sebaceous</td> </tr> <tr> <td class="indent1">Schimmelpenning syndrome, NS<sup>[4]</sup></td> <td>RAS SNaPshot assay, Sanger sequencing</td> <td class="centered">1/2<br/> 59/65</td> <td class="centered">1/65</td> <td class="centered">1/65</td> <td class="centered">G12S (3/65), A11S</td> <td class="centered">1/2<br/> 2/65</td> <td class="centered">1/65</td> <td class="centered"> </td> <td> </td> </tr> <tr> <td class="indent1">NS<sup>◊</sup><sup>[5]</sup></td> <td>WES of index cases, Sanger sequencing</td> <td class="centered">25/27</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">1/27</td> <td class="centered">1/27</td> <td class="centered"> </td> <td> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Schimmelpenning syndrome (index), NS<sup>[6]</sup></td> <td>WES of index case, Sanger sequencing</td> <td class="centered">1/1<br/> 24/31</td> <td class="centered">1/31</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">2/31</td> <td class="centered"> </td> <td class="centered"> </td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="10">PPK</td> </tr> <tr class="divider_bottom"> <td class="indent1">Nevus spilus plus NS<sup>[7]</sup></td> <td>RAS SNaPshot assay, Sanger sequencing</td> <td class="centered">4/6</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">G61R<br/> (2/6)</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="10">Melanocytic</td> </tr> <tr> <td class="indent1">Agminated segmental nevi<sup>Δ</sup><sup>[8]</sup></td> <td>Sanger sequencing</td> <td class="centered">1/1</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td><em>BRAF</em> V600E</td> </tr> <tr> <td class="indent1">Nevus spilus plus overlying agminated Spitz nevi<sup>Δ[9]</sup></td> <td>WES-aCGH</td> <td class="centered">1/1</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td>Copy number increase in chromosome 11p in overlying Spitz nevi</td> </tr> <tr> <td class="indent1">Nevus spilus<sup>[10]</sup></td> <td>Sanger sequencing</td> <td class="centered">8/8</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td>–</td> </tr> <tr> <td class="indent1">Nevus spilus-type CMN<sup>[11]</sup></td> <td>WES</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">G13R, Q61H (2/3)</td> <td> </td> </tr> </tbody></table></div><div class="graphic_footnotes">KEN: keratinocytic epidermal nevi; WGA-aCGH: whole genome amplification-array comparative genomic hybridization; NS: nevus sebaceous; WES: whole exome sequencing; PPK: phakomatosis pigmentokeratotica; CMN: congenital melanocytic nevus.<br/>* Analyses techniques are summarized but may not reflect the breakdown of additional methods used. Refer to original study for details. En dash (–) indicates genes not screened.<br/>¶ Mutations listed under other are present in one sample of the total tested only unless otherwise indicated.<br/>Δ Case report.<br/><font class="lozenge">◊</font> Merged data. Breakdown: 3/5 <em>HRAS</em> G13R (two additional separate sets were 11/11 and 11/11 for this mutation), 1/5 <em>KRAS</em> G12D, and 1/5 <em>KRAS</em> G12V.</div><div class="graphic_reference">References:

<ol>
<li>Hafner C, Toll A, Real FX. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus. N Engl J Med 2011; 365:1940.</li>
<li>Hafner C, Toll A, Gantner S, et al. Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet 2012; 49:249.</li>
<li>Bourdeaut F, Hérault A, Gentien D, et al. Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma. J Med Genet 2010; 47:859.</li>
<li>Groesser L, Herschberger E, Ruetten A, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 2012; 44:783.</li>
<li>Levinsohn JL, Tian LC, Boyden LM, et al. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceous. J Invest Dermatol 2013; 133:827.</li>
<li>Sun BK, Saggini A, Sarin KY, et al. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol 2013; 133:824.</li>
<li>Groesser L, Herschlberger E, Sagrera A, et al. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol 2013; 133:1998.</li>
<li>Luo S, Chaplin AC, Langley RG, et al. Agminated segmental nevi demonstrating intranevic concordance of BRAF status. J Invest Dermatol 2011; 131:788.</li>
<li>Sarin KY, Sun BK, Bangs CD, et al. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatol 2013; 149:1077.</li>
<li>Sarin KY, McNiff JM, Kwok S, et al. Activating HRAS mutation in nevus spilus. J Invest Dermatol 2014; 134:1766.</li>
<li>Kinsler VA, Krengel S, Riviere JB, et al. Next-generation sequencing of nevus spilus-type congenital melanocytic nevus: exquisite genotype-phenotype correlation in mosaic RASopathies. J Invest Dermatol 2014; 134:2658.</li>
</ol>

Reproduced from: Luo S, Tsao H. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies. J Invest Dermatol 2014; 134:2493. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 114391 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
